Search Results 141-150 of 228 for ⏳담보대출 텔레:ABK0119 소액대출 급전대출 100만대출⏳

  1. Neurology - Clinical trials - Mayo Clinic

    It is not yet known whether giving memantine hydrochloride and WBRT with or without hippocampal avoidance works better in reducing neurocognitive decline in ...

  2. Study of Auditory Function through Intra- and Post-operative Measurements - Mayo Clinic

    The purpose of this study is to determine if electrocochleography (ECochG) measurements performed during cochlear implant surgery can be used to monitor ...

  3. ... 100 gram intravenous solution,962.5 636000003,49281012088,flu vaccine qs2020 ... 100 mg/5 mL intravenous solution,ofatumumab 1,000 mg/50 mL intravenous ...

  4. ... 100 mg tablet,6.2 1964,637000000,50268032411,flavoxATE 100 mg tablet,9.12 2026,637000000,50268032011,flecainide 50 mg tablet,8.72 2042,637000000,54001020 ...

  5. ... 100 301000323,HC HEXOSAMINIDASE LEUKOCYTES,139 301000324,HC HEXOSAMINIDASE SERUM,139 301000325,HC HGB ELECTROPHORESIS FRACT/QUANT,107 301000326,HC HGB O2 ...

  6. ... 100 mg tablet,6.2 637000000,51224015450,flavoxATE 100 mg tablet,7.19 637000000,54001021,flecainide 50 mg tablet,5.73 637000000,904650061,fluconazole 100 mg ...

  7. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effect of rilonacept added to standard therapy on improvement in myocardial inflammation in ...

  8. Vascular centers - Clinical trials

    The purpose of this study is to evaluate different techniques to repair internal iliac artery aneurysms. Report short and long term clinical outcomes with ...

  9. Publications - Waleed Brinjikji, M.D. - Mayo Clinic

    Brinjikji W, Kottenmeier E, Kabiri M, Khaled A, Pederson JM, Al-Bayati AR. Estimating the impact of balloon guide catheter with mechanical thrombectomy for ...

  10. 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

    The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by ...